Buscar
01/08/2022
Reduction in Preterm Preeclampsia after Contingent First-Trimester Screening and Aspirin Prophylaxis in a Routine Care Setting
Trilla, C, Mora, J, Ginjaume, N, Nan, MN, Alejos, O, Dominguez, C, Vega, C, Godinez, Y, Cruz-Lemini, M, Parra, J, Llurba, E. Reduction in Preterm Preeclampsia after Contingent First-Trimester Screening and Aspirin Prophylaxis in a Routine Care Setting. Diagnostics. 2022; 12(8)DOI:10.3390/diagnostics12081814. PMID:36010165. IF:3.600(Q2/4D).
26/07/2022
First-Trimester Sequential Screening for Preeclampsia Using Angiogenic Factors: Study Protocol for a Prospective, Multicenter, Real Clinical Setting Study
Trilla, C, Luna, C, Socorro, SD, Rodriguez, L, Ruiz-Romero, A, Brugues, JM, Delgado, TB, Fabre, M, Martinez, AM, Ruiz-Martinez, S, Llurba, E, Oros, D. First-Trimester Sequential Screening for Preeclampsia Using Angiogenic Factors: Study Protocol for a Prospective, Multicenter, Real Clinical Setting Study. Frontiers in Cardiovascular Medicine. 2022; 9DOI:10.3389/fcvm.2022.931943. PMID:35958398. IF:3.600(Q2/5D).
01/05/2022
First-Trimester SARS-CoV-2 Infection: Clinical Presentation, Inflammatory Markers, and Obstetric Outcomes
Trilla C., Mora J., Crovetto F., Crispi F., Gratacos E., Llurba E.. First-Trimester SARS-CoV-2 Infection: Clinical Presentation, Inflammatory Markers, and Obstetric Outcomes. FETAL DIAGNOSIS AND THERAPY. 2022; 49(3)DOI:10.1159/000523974. PMID:35263747. IF:2.200(Q3/7D).
01/04/2022
Impact of the COVID-19 Pandemic on Maternal Well-Being during Pregnancy
Pascal, R, Crovetto, F, Casas, I, Youssef, L, Trilla, C, Larroya, M, Cahuana, A, Boada, D, Foraster, M, Llurba, E, Sunyer, J, Crispi, F, Gratacos, E, Gomez-Roig, MD. Impact of the COVID-19 Pandemic on Maternal Well-Being during Pregnancy. Journal of Clinical Medicine. 2022; 11(8)DOI:10.3390/jcm11082212. PMID:35456306. IF:3.900(Q2/4D).